相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Oxidative Stress Product, 4-Hydroxy-2-Nonenal, Induces the Release of Tissue Factor-Positive Microvesicles From Perivascular Cells Into Circulation
Shabbir A. Ansari et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report
Axel Rosell et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung
Alan E. Mast et al.
ELIFE (2021)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 and its implications for thrombosis and anticoagulation
Jean M. Connors et al.
BLOOD (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia
David Lillicrap
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses
Nigel Mackman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
Mario Bautista-Vargas et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
Eugenio D. Hottz et al.
BLOOD (2020)
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
Panagiotis Skendros et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells
Alexander Carpinteiro et al.
CELL REPORTS MEDICINE (2020)
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
Sebastian Schloer et al.
EMERGING MICROBES & INFECTIONS (2020)
Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity
Jue Wang et al.
BLOOD (2019)
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding
Jue Wang et al.
BLOOD ADVANCES (2017)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Secretory sphingomyelinase in health and disease
Johannes Kornhuber et al.
BIOLOGICAL CHEMISTRY (2015)
Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation
Florian Langer et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Regulation of tissue factor coagulant activity on cell surfaces
L. V. M. Rao et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids
Delphine Milhas et al.
FEBS LETTERS (2010)
Induction of Membrane Ceramides: A Novel Strategy to Interfere with T Lymphocyte Cytoskeletal Reorganisation in Viral Immunosuppression
Evelyn Gassert et al.
PLOS PATHOGENS (2009)
Infections with human rhinovirus induce the formation of distinct functional membrane domains
Stephan Dreschers et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms
H Grassmé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)